Request Customization - Arterial Cannula Market | Growing With 6.5% CAGR By 2028

Global Arterial Cannula Market Research Report: Forecast (2023-2028)

By Product (Cardiac Cannulas, Nasal Cannulas, Vascular Cannulas, Dermatology Cannulas, Arthroscopy Cannulas, Arthroscopy Cannulas), By Type (Neonatal Cannulas, Straight Cannulas, Winged Cannula, Wing... ... inged Cannula, Wing with Port Cannula, Others), By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), By Material (Plastic [PVC] Cannulas, Silicone Cannulas, Metal Cannulas [Stainless Steel]), By Application (Cardiovascular Surgery, Oxygen Therapy, General Surgery, Cosmetic/Plastic Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgery Centers [ASCs], Others), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences , LivaNova Plc, Medtronic Plc , Smith & Nephew PLC, Smiths Medical Inc., Teleflex Incorporated, Terumo Corporation, others) Read more

Healthcare
Apr 2023
Pages 174
Report Format: PDF, Excel, PPT

Market Definition

An Arterial Cannula is a flexible plastic tube designed to deliver blood to the patient during cardiopulmonary bypass. The procedure involved is called Arterial cannulation, which is frequently performed in acute and critical care settings. It is an invasive means to measure blood and mean arterial pressure more accurately than non-invasive means.

Market Insights & Analysis: Global Arterial Cannula Market (2023-28)

The Global Arterial Cannula Market is projected to grow at a CAGR of around 6.5% during the forecast period, i.e., 2023-28. The worldwide prevalence of heart disorders has increased over the years due to various factors such as consuming unhealthy diets, sedentary lifestyles, increasing smoking habits, physical inactivity, or family history of chronic disorders such as hypertension, diabetes, or hyperlipidemia to contribute to the rising incidence of cardiovascular diseases. Thus, the growing prevalence of cardiovascular and cardiopulmonary illnesses that require cardiopulmonary pass surgery CABG, dialysis, and Extracorporeal Membrane Oxygenation ECMO aids the demand for arterial cannula.

Recent studies have shown that more than half of patients in the intensive care unit with kidney injury may require dialysis, while over one-third of patients hospitalized with COVID-19 may develop kidney injury, indicating a potential rise in health issues related to the heart and kidneys. Thus, there is a growing preference for minimally invasive techniques as it facilitates less pain, quicker recovery, further fueling the demand for arterial cannulas for surgical procedures.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	6.5%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Argentina, Rest of South America
	Middle East & Africa: UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of the Middle East & Africa
Key Companies Profiled	Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences , LivaNova Plc, Medtronic Plc , Smith & Nephew PLC, Smiths Medical Inc., Teleflex Incorporated, Terumo Corporation, others
Unit Denominations	USD Million/Billion

According to the fact sheet updated by the American Heart Association in 2022, North Africa & the Middle East, Central, & South Asia, and Eastern Europe had the highest prevalence rates of ischemic heart disease (IHD) in the world in 2020. Citing the high level of mortality due to IHD, the respective government across the regions seeks to improve healthcare infrastructure through numerous initiatives in order to strengthen medical care and minimize the cases, broadening the industry's potential.

Market Dynamics

Key Driver: Prevalence of Cardiovascular and Cardiopulmonary Illnesses Resulting in Immediate Need for By-Pass Surgeries

According to the study, The Global Burden of Cardiovascular Diseases and Risk, published by JACC, Journal of the American College of Cardiology in December 2022, Cardiovascular diseases (CVDs) have collectively remained the leading causes of death globally, substantially contributing to the loss of health and additional costs on the health system. The more frequent instances of kidney dysfunction, dietary risks, tobacco smoking, secondhand tobacco smoke, high systolic blood pressure, high LDL-C, high body mass index (BMI), high fasting plasma glucose, high alcohol use, and low physical activity as the possible risk factors are anticipated to raise the chances of such diseases.

Given the criticality of such conditions and the immediate urge to minimize them, invasive and efficacious surgical techniques are surfacing, giving rise to innovative medical devices, including arterial cannulae, by numerous manufacturers. For instance,

Medtronic plc, an American medical device company, has come up with product variations to facilitate a variety of surgical techniques and to accommodate varying patient anatomies. In fact, citing the need for distinct devices for pediatrics and adults, the company offers arterial cannulae sizes from 6 Fr to 24 Fr in various tip configurations, lengths, and connector sizes.

Thus, rising cardiovascular conditions and pulmonary illnesses has increased the number of bypass surgeries and other similar procedures, particularly among the geriatric population, significantly elevating the demand for cannulae market.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
Market Segmentation
Executive Summary
Global Arterial Cannula Market Regulations, Norms, & Product Standards
Global Arterial Cannula Market Trends & Developments
Global Arterial Cannula Market Dynamics
1. Drivers
2. Challenges
Global Arterial Cannula Market Imports, Exports Statistics
Global Arterial Cannula Market Hotspots & Opportunities
Global Arterial Cannula Market Value Chain & Stakeholder Margin Analysis
Global Arterial Cannula Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
    1. Cardiac Cannulas
    2. Nasal Cannulas
    3. Vascular Cannulas
    4. Dermatology Cannulas
    5. Arthroscopy Cannulas
    6. Arthroscopy Cannulas
  2. By Type
    1. Neonatal Cannulas
    2. Straight Cannulas
    3. Winged Cannula
    4. Wing with Port Cannula
    5. Others
  3. By Size
    1. 14G
    2. 16G
    3. 18G
    4. 20G
    5. 22G
    6. 24G
    7. 26G
  4. By Material
    1. Plastic (PVC) Cannulas
    2. Silicone Cannulas
    3. Metal Cannulas (Stainless Steel)
  5. By Application
    1. Cardiovascular Surgery
    2. Oxygen Therapy
    3. General Surgery
    4. Cosmetic/Plastic Surgery
    5. Orthopedic Surgery
    6. Others
  6. By End User
    1. Hospitals
    2. Ambulatory Surgery Centers (ASCs)
    3. Others
  7. By company
    1. Revenue Shares
    2. Competition Characteristics
  8. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
North America Arterial Cannula Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
  2. By Type
  3. By Size
  4. By Material
  5. By Application
  6. By End User
  7. BY company
  8. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
4. Canada Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
5. Mexico Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
South America Arterial Cannula Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
  2. By Type
  3. By Size
  4. By Material
  5. By Application
  6. By End User
  7. BY company
  8. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
4. Argentina Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
Europe Arterial Cannula Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
  2. By Type
  3. By Size
  4. By Material
  5. By Application
  6. By End User
  7. BY company
  8. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
4. France Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
5. The UK Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
6. Spain Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
7. Italy Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
The Middle East & Africa Arterial Cannula Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
  2. By Type
  3. By Size
  4. By Material
  5. By Application
  6. By End User
  7. BY company
  8. By Country
    1. The UAE
    2. Saudi Arabia
    3. Qatar
    4. Egypt
    5. South Africa
    6. Rest of the Middle East & Africa
3. The UAE Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
4. Saudi Arabia Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
5. Qatar Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
6. Egypt Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
7. South Africa Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
Asia-Pacific Arterial Cannula Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
  2. By Type
  3. By Size
  4. By Material
  5. By Application
  6. By End User
  7. BY company
  8. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
4. India Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
5. Japan Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
6. South Korea Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
7. Australia Arterial Cannula Market Analysis (2018-2028F)
  1. By Type
  2. By End User
Competitive Benchmarking & Company Profiles
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances
  6. Strategic Initiatives
2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc)
  1. Boston Scientific Corporation
  2. CONMED Corporation
  3. Edwards Lifesciences
  4. LivaNova Plc
  5. Medtronic Plc
  6. Smith & Nephew PLC
  7. Smiths Medical Inc.
  8. Teleflex Incorporated
  9. Terumo Corporation
  10. others
Copyright & Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Name *

Email *

Country *